Table 8.
Factors Associated with Recurrence-Free Survival at Two Years in the Studied Group
| n | Events | Cumulative Survival Proportion (%) | p-value | ||
|---|---|---|---|---|---|
| Sarcopenia | Yes | 42 | 6 | 76.5 | 0.176 |
| No | 55 | 6 | 88.0 | ||
| Age (years) | > 50 | 66 | 8 | 83.9 | 0.984 |
| ≤ 50 | 31 | 4 | 84.7 | ||
| Sex | Male | 72 | 10 | 82.4 | 0.461 |
| Female | 25 | 2 | 89.2 | ||
| Diabetes mellitus | Yes | 22 | 4 | 77.8 | 0.453 |
| No | 75 | 8 | 86.3 | ||
| Child Class | A | 64 | 10 | 81.0 | 0.214 |
| B | 33 | 2 | 90.7 | ||
| MELD score | > 9 | 56 | 6 | 86.8 | 0.341 |
| ≤ 9 | 41 | 6 | 80.9 | ||
| ALBI Grade | G1 | 66 | 9 | 82.9 | 0.624 |
| G2 | 31 | 3 | 87.0 | ||
| S. Creatinine (mg/dL) | > 1.2 | 20 | 3 | 83.0 | 0.853 |
| ≤ 1.2 | 77 | 9 | 84.6 | ||
| Hemoglobin (gm/dL) | < 12 | 69 | 7 | 86.9 | 0.382 |
| ≥ 12 | 28 | 5 | 77.9 | ||
| ALT (U/L) | > 55 | 29 | 5 | 78.8 | 0.481 |
| ≤ 55 | 68 | 7 | 87.0 | ||
| AST (U/L) | > 40 | 92 | 12 | 83.4 | 0.434 |
| ≤ 40 | 5 | 0 | 100.0 | ||
| INR | > 1.1 | 93 | 12 | 83.6 | 0.520 |
| ≤ 1.1 | 4 | 0 | 100.0 |
Abbreviations: MELD, Model for End-stage Liver Disease; ALBI, albumin-bilirubin grade; Hb, hemoglobin; ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, international normalized ratio.